fluconazole has been researched along with gentian violet in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, S; Clancy, CJ; Clapp, W; Nguyen, KT; Nguyen, MH | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Johnson, EM; Warnock, DW; White, DJ | 1 |
| Gaskie, S; Jamieson, B; Su, CW; Triezenberg, D | 1 |
| Gambhir, IS; Gulati, AK; Nigam, C; Prakash, P; Tilak, R; Tilak, V | 1 |
| Arthington-Skaggs, BA; Bizerra, FC; Colombo, AL; Freymüller, E; Melo, AS | 1 |
| Gaspar, C; Gomes-de-Elvas, AR; Gouveia, P; Martinez-de-Oliveira, J; Palmeira-de-Oliveira, A; Palmeira-de-Oliveira, R; Pina-Vaz, C; Rodrigues, AG | 1 |
| Matos, T; Raspor, P; Tomičić, Z; Zupan, J | 1 |
1 review(s) available for fluconazole and gentian violet
| Article | Year |
|---|---|
Clinical inquiries. What is the best treatment for oral thrush in healthy infants?
Topics: Administration, Oral; Anti-Infective Agents, Local; Antifungal Agents; Candidiasis, Oral; Evidence-Based Medicine; Family Practice; Fluconazole; Gentian Violet; Humans; Infant; Infant Care; Infant, Newborn; Nystatin; Practice Guidelines as Topic | 2008 |
7 other study(ies) available for fluconazole and gentian violet
| Article | Year |
|---|---|
A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Drug Resistance, Fungal; Fluconazole; Microbial Sensitivity Tests; Mutation; Oxidative Phosphorylation; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata.
Topics: Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Resistance, Microbial; Econazole; Female; Fluconazole; Gentian Violet; Humans; Itraconazole; Ketoconazole; Medroxyprogesterone Acetate; Microbial Sensitivity Tests; Nystatin | 1993 |
Cryptococcal meningitis with an antecedent cutaneous Cryptococcal lesion.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Carbon; Coloring Agents; Cryptococcosis; Cryptococcus gattii; Dermatomycoses; Fluconazole; Foot Ulcer; Fungemia; Gentian Violet; HIV Seronegativity; Humans; Male; Meningitis, Cryptococcal; Phenazines; Staining and Labeling; Toes | 2009 |
Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Fluconazole; Gentian Violet; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Staining and Labeling; Tetrazolium Salts | 2011 |
In vitro assessment of gentian violet anti- candida activity.
Topics: Antifungal Agents; Candida; Candida albicans; Candida tropicalis; Candidiasis, Vulvovaginal; Female; Fluconazole; Gentian Violet; Humans; Microbial Sensitivity Tests | 2012 |
Probiotic yeast Saccharomyces boulardii (nom. nud.) modulates adhesive properties of Candida glabrata.
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Cell Adhesion; Fluconazole; Gentian Violet; Humans; Hydrogen-Ion Concentration; Itraconazole; Lacticaseibacillus casei; Lacticaseibacillus rhamnosus; Microbial Interactions; Saccharomyces boulardii; Staining and Labeling; Temperature | 2016 |